Trials / Withdrawn
WithdrawnNCT03884400
Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
iSpecimen Network Distribution of Biospecimens From Biorepositories/Biobanks for Research Use
- Status
- Withdrawn
- Phase
- —
- Study type
- Observational
- Enrollment
- 0 (actual)
- Sponsor
- iSpecimen Inc · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Accepted
Summary
This protocol seeks to assist biorepositories/biobanks in distributing their stored specimens and data to researchers that will actually utilize them to advance medicine and technology.
Detailed description
iSpecimen has built a partner network comprised of supplying institutions that have ethically acquired human biospecimens and created biorepositories/biobanks to store the specimens and data. Many of these biorepositories have protocols allowing for the collection of their samples but require an additional IRB or ethics review for the distribution of their samples. This protocol establishes a method of such supply sites to allow their specimens to be distributed and used for research via iSpecimen's technology and network of research clients.
Conditions
- Cancer
- Pregnancy Related
- Gastro-Intestinal Disorder
- Cardio-Respiratory Distress
- Women's Health: Endometriosis
- Autoimmune Diseases
- Nephritis
- Healthy
- Neuro-Degenerative Disease
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Specimens obtained from surgical, phlebotomy or other non-invasive procedure | Biospecimen Collection |
Timeline
- Start date
- 2021-01-01
- Primary completion
- 2025-12-31
- Completion
- 2026-03-01
- First posted
- 2019-03-21
- Last updated
- 2022-11-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03884400. Inclusion in this directory is not an endorsement.